NSC 210902

Casein Kinase 2 (CK2) is a serine/threonine-selective protein kinase involved in many signal transduction pathways. CK2 is known to negatively regulate apoptosis, and its activity is increased in many proliferating tissues and tumors, which lends promise as an anticancer drug target. NSC 210902 inhibits CK2 with an IC50 value of 1 µM and competitively inhibits binding of ATP with a Ki value of 0.28 µM. NSC 210902 is selective for CK2 as it only minimally inhibits the activities of other protein kinases (e.g., JNK3, GSK3, Cdk5, and MSK1).Formal Name: 1,4-dihydro-4-oxo-benzo[h]quinoline-3-carboxylic acid. CAS Number: 51726-83-1. Molecular Formula: C14H9NO3. Formula Weight: 239.2. Purity: >95%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 0.1 mg/mL, DMSO: 0.2 mg/mL. lambdamax: 213, 256, 318, 349 nm. SMILES: OC(=O)c1c[nH]c2c(ccc3ccccc23)c1=O. InChi Code: InChI=1S/C14H9NO3/c16-13-10-6-5-8-3-1-2-4-9(8)12(10)15-7-11(13)14(17)18/h1-7H,(H,15,16)(H,17,18). InChi Key: QGOKEDVMXJBTAR-UHFFFAOYSA-N.